EnteroBiotix which is developing treatments based on the body’s own microorganisms has raised £500,000 in its first round of equity funding, including a £100,000 grant from SMART Scotland, plus £400,000 in financing led by the Equity Gap angel syndicate and supported by Scottish Investment Bank.
